Emory University: Prostatic Neoplasms trials

The registry lists 24 Prostatic Neoplasms studies with Emory University as lead sponsor. 7 are open to participants now and 11 have results posted.

Phase 1 1Phase 2 12Phase 3 2No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Pluvicto for the Treatment of African American Men With Metastatic Castration-Resistant Prostate CancerNot yet recruitingNCT07860554Phase 2
• CT- Versus MRI-Based Planning for High-Dose-Rate Prostate Brachytherapy for Prostate CancerNot yet recruitingNCT07859722Not applicable
• An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion TechniqueRecruitingNCT06865768Phase 2
• Addressing Health Literacy With a Tailored Survivorship Care PlanRecruitingNCT06674863Not applicable
• REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac TrialRecruitingNCT06650579Phase 3
• Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate CancerRecruitingNCT04725903Not applicable
• Improving Health Literacy in African-American Prostate Cancer PatientsRecruitingNCT03322891Not applicable
• Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate CancerActive, not recruitingNCT05779943Phase 2Results posted
• RElugolix VErsus LeUprolide Cardiac TrialActive, not recruitingNCT05320406Phase 2Results posted
• Soccer Intervention in Prostate Cancer SurvivorsCompletedNCT04144127Not applicableResults posted
• MRI Guided Prostate Cancer Focal Laser AblationTerminatedNCT03634579Not applicableResults posted
• Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients With Metastatic Castration Resistant Prostate CancerCompletedNCT03448458Phase 2Results posted
• Validation of FACBC for Detection of Metastasis Among High-risk Prostate Cancer Patients With Presumed Localized DiseaseCompletedNCT03081884Phase 2Results posted
• FACBC Prostate Therapy ResponseCompletedNCT02830880Phase 2Results posted
• Genistein Supplementation to Mitigate Cardiometabolic Dysfunction in Patients Undergoing Androgen Deprivation Therapy for Prostate CancerTerminatedNCT02766478Phase 2Results posted
• Targeted Fusion Biopsy of the ProstateCompletedNCT02744534Phase 2Results posted
• Fusion Targeted Biopsy of the ProstateCompletedNCT02013414Not applicableResults posted
• FACBC Outcomes for Post ProstatectomyCompletedNCT01666808Phase 2/3Results posted
• Vudalimab (XmAb20717) in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate CancerTerminatedNCT05733351Phase 1
• Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resistant Prostate CancerSuspendedNCT05445609Phase 2
• Comprehensive Yoga Program (SKY) as Adjunct Therapy for Prostate CancerCompletedNCT03220945Not applicable
• Efficacy of Massage for the Treatment of Cancer-Related Fatigue (CRF) in Prostate Cancer SurvivorsCompletedNCT03187275Not applicable
• Botulinum Toxin Injection With Prostate BrachytherapyWithdrawnNCT00681148Phase 2
• A Randomized Controlled Trial to Promote Physician-Patient Discussion of Prostate Cancer ScreeningCompletedNCT00208988Not applicable